Filter
833
Text search:
TB
burden
Featured
Recommendations
74
New Publications
201
Language
Document type
No document type
521
Studies & Reports
129
Guidelines
76
Strategic & Response Plan
43
Manuals
25
Fact sheets
16
Situation Updates
11
Training Material
8
Resource Platforms
3
Infographics
1
Countries / Regions
India
34
Kenya
33
South Africa
33
Global
33
Western and Central Europe
27
Malawi
23
Tanzania
19
Eastern Europe
19
Ethiopia
17
Africa
17
Nigeria
16
Namibia
16
Uganda
14
Rwanda
14
Ghana
13
Zambia
13
Sierra Leone
12
Liberia
10
Bangladesh
10
Ukraine
10
South–East Asia Region
10
Nepal
9
Myanmar / Burma
9
Latin America and the Carribbean
9
Asia
9
Cambodia
8
Lesotho
8
Zimbabwe
6
Russia
6
Congo, Democratic Republic of
4
Philippines
4
Syria
4
Indonesia
4
Mozambique
4
Botswana
4
Senegal
3
South Sudan
3
Peru
3
Pakistan
2
East and Southern Africa
2
Middle East and North Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
Tajikistan
2
Guinea
1
Burkina Faso
1
USA
1
Cameroon
1
Haiti
1
Jordan
1
Afghanistan
1
Germany
1
Lebanon
1
Papua New Guinea
1
Sudan
1
Benin
1
Central African Republic
1
Argentina
1
Eswatini/ Swaziland
1
Brazil
1
Burundi
1
Colombia
1
Ecuador
1
Sri Lanka
1
Yemen
1
West and Central Africa
1
Bhutan
1
Venezuela
1
Southern Africa
1
Timor Leste/ East Timor
1
Moldova
1
Iran
1
Georgia
1
Vietnam
1
Gabon
1
Turkmenistan
1
Jamaica
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
342
Clinical Guidelines
62
Public Health
32
Key Resources
20
Women & Child Health
18
Pharmacy & Technologies
6
Capacity Building
5
Toolboxes
TB
211
HIV
118
AMR
40
COVID-19
36
Mental Health
20
Caregiver
18
Global Health Education
14
NTDs
13
NCDs
13
Health Financing Toolbox
12
Conflict
11
Refugee
10
Planetary Health
9
Natural Hazards
8
Pharmacy
8
Disability
7
Polio
6
Ebola & Marburg
2
Rapid Response
2
Social Ethics
2
Cholera
1
Zika
1
Specific Hazards
1
2.0 Rapid Response
1
Discussion paper initially prepared in April 2015 to facilitate feedback, and finalized after the
June 2015 meeting of WHO’s Strategic and Technical Advisory Group for TB (STAG-TB).
Tuberculosis (TB) is the deadliest infectious disease in most low- and middle-income countries, claiming more than 4,000 lives each day. The unprecedented COVID-19 pandemic has seriously impacted people with pre-existing health conditions. People wi
...
Public Health Action PHA 2017; 7(2): 110–115
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans
...
Globally, it is estimated that 1 billion people suffer from acute and chronic respiratory conditions, making them major causes of illness and death. Although there is a relative lack of data and evidence on lung diseases beyond tuberculosis (TB) in
...
The WHO End TB Strategy aims to end the global TB epidemic by 2030, in alignment with Goal 3 of the United Nations (UN) Sustainable Development Goals (SDGs). Member States of the World Health Organi
...
12 countries have a high TB estimated burden with an incidence rate more than 45 per 100 000 population They represent 88 of the cases in the Region
In 2019 the
...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including posi
...
There is paucity of data on the burden and specific drivers operative in the pathogenesis of chronic obstructive pulmonary disease (COPD) in the African setting and populations. Lack of awareness and inadequate knowledge on the aetio-pathogenesis of
...
The Creditor Reporting System was analysed for official development assistance funding disbursements towards TB control in 11 conflict-affectedstates, 17 non-conflict-affected fragile states and 38 comparable non-fragile states. The amounts of fundi
...
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and afford
...
The World Health Organization (WHO) is releasing the second edition of its Global Accelerated Action for the Health of Adolescents (AA-HA!) guidance. The document aims to equip governments to respond to the health and well-being challenges, opportunities and needs of adolescents.
The guidance pro
...
Antimicrobial resistance (AMR) has emerged as a leading cause of death in the African region, surpassing fatalities from malaria, HIV, and TB. In response to this critical threat, the region has adopted the AMR Global Action Plan and the African Uni
...
This report is one of the first major products of the newly established Precision Public Health Metrics unit of the UCN cluster of the WHO Regional Office for Africa. The report presents national trends in communicable and non-communicable disease burden
...
Eur Respir J 2017; 50: 1700918
Anti-tuberculosis drug resistance among tuberculosis patients in Ukraine and risk factors for MDR-TB
Results of the first national survey, 2013–2014
The results of the SHINE trial have been published in the NEJM today. SHINE looked at whether treatment for children with minimal TB could be reduced from 6 months to 4 months. It found that the four month treatment was as good as the standard six m
...
End TB.
Accessed in November 2017.
